Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
22 Results for "
Retinol Binding Protein 4
" in MedChemExpress (MCE) Product Catalog:
Products (22)
22 Results for "Retinol Binding Protein 4" in MCE Product Catalog:
1
1 Cited Publications
Target:
Research Areas:
A 1120 is a high-affinity nonretinoid retinol-binding protein 4 (RBP4) antagonist with a Ki value of 8.3 nM. A 1120 disrupts the interaction between RBP4 and its binding partner transthyretin .
1
1 Cited Publications
Cat. No.: HY-P72031
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: RBP4; Retinol-Binding Protein 4, Interstitial; Retinol Binding Protein 4; Retinol-Binding Protein 4, Plasma; Plasma Retinol-Binding Protein; Retinol Binding Protein 4, Plasma; Retinol-Binding Protein 4; Retinol-Binding Protein; PRBP; MCOPCB10; RBP; RDCCAS
Species:
Human
Source:
HEK293
1
1 Cited Publications
Cat. No.: HY-P74598
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: RBP4; Retinol-Binding Protein 4, Interstitial; Retinol Binding Protein 4; Retinol-Binding Protein 4, Plasma; Plasma Retinol-Binding Protein; Retinol Binding Protein 4, Plasma; Retinol-Binding Protein 4; Retinol-Binding Protein; PRBP; MCOPCB10; RBP; RDCCAS
Species:
Rat
Source:
HEK293
Target:
Research Areas:
RBP4 inhibitor 1 (compound 43b) is a potent and orally active retinol-binding protein 4 (RBP4) inhibitor with IC50s of 28 nM and 110 nM for human and mouse RBP4. RBP4 inhibitor 1 has a potent and long-lasting blood RBP4-level-reducing effect in mice .
Synonyms: LBS-008; BPN-14967
Target:
Research Areas:
Tinlarebant (LBS-008) is an orally active non-retinoid RBP4 (retinol-binding protein 4) antagonist. Tinlarebant can be used for the research of the Stargardt disease .
Cat. No.: HY-P85634
Synonyms: OTTHUMP00000020114; OTTHUMP00000020115; OTTHUMP00000020116; Plasma Retinol Binding Protein 4; Plasma Retinol-Binding Protein; Plasma Retinol-Binding Protein; 1-176; PRBP; PRO2222; RBP; RBP4; RDCCAS; RET4_HUMAN; Retinol Binding Protein 4; Retinol Binding Protein 4 interstitial; Retinol Binding Protein 4 plasma.
Cat. No.: HY-P70471
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: RBP4; Retinol-Binding Protein 4, Interstitial; Retinol Binding Protein 4; Retinol-Binding Protein 4, Plasma; Plasma Retinol-Binding Protein; Retinol Binding Protein 4, Plasma; Retinol-Binding Protein 4; Retinol-Binding Protein; PRBP; MCOPCB10; RBP; RDCCAS
Species:
Human
Source:
E. coli
Cat. No.: HY-172232
CAS No.: 1911650-53-7
Target:
Research Areas:
STG-001 is a retinol binding protein 4 (RBP4) antagonist. STG-001 inhibits RBP4 to reduce the synthesis of retinal and diretinol, thereby preventing photoreceptor degeneration. STG-001 can be used in the study of sexually precocious nephropathy (STGD) .
Cat. No.: HY-147366
CAS No.: 260553-24-0
Target:
Research Areas:
RBP4 ligand-1 is a non-retinoid ligands for (RBP4) retinol-binding protein 4. The hRBP4SPA IC50 and RBP4-TTR FRET IC50 values are 0.23±0.11 and 0.13±0.12 μM in the radioligand binding assay and FRET assay, respectively .
Cat. No.: HY-P74599
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: RBP4; Retinol-Binding Protein 4, Interstitial; Retinol Binding Protein 4; Retinol-Binding Protein 4, Plasma; Plasma Retinol-Binding Protein; Retinol Binding Protein 4, Plasma; Retinol-Binding Protein 4; Retinol-Binding Protein; PRBP; MCOPCB10; RBP; RDCCAS
Species:
Mouse
Source:
HEK293
Cat. No.: HY-P76000
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: RBP4; Retinol-Binding Protein 4, Interstitial; Retinol Binding Protein 4; Retinol-Binding Protein 4, Plasma; Plasma Retinol-Binding Protein; Retinol Binding Protein 4, Plasma; Retinol-Binding Protein 4; Retinol-Binding Protein; PRBP; MCOPCB10; RBP; RDCCAS
Species:
Canine
Source:
HEK293
Cat. No.: HY-P76001
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: RBP4; Retinol-Binding Protein 4, Interstitial; Retinol Binding Protein 4; Retinol-Binding Protein 4, Plasma; Plasma Retinol-Binding Protein; Retinol Binding Protein 4, Plasma; Retinol-Binding Protein 4; Retinol-Binding Protein; PRBP; MCOPCB10; RBP; RDCCAS
Species:
Canine
Source:
HEK293
Cat. No.: HY-P77171
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: RBP4; Retinol-Binding Protein 4, Interstitial; Retinol Binding Protein 4; Retinol-Binding Protein 4, Plasma; Plasma Retinol-Binding Protein; Retinol Binding Protein 4, Plasma; Retinol-Binding Protein 4; Retinol-Binding Protein; PRBP; MCOPCB10; RBP; RDCCAS
Species:
Cynomolgus
Source:
HEK293
Cat. No.: HY-P72031A
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: RBP4; Retinol-Binding Protein 4, Interstitial; Retinol Binding Protein 4; Retinol-Binding Protein 4, Plasma; Plasma Retinol-Binding Protein; Retinol Binding Protein 4, Plasma; Retinol-Binding Protein 4; Retinol-Binding Protein; PRBP; MCOPCB10; RBP; RDCCAS
Species:
Human
Source:
HEK293
Cat. No.: HY-P71251A
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: RBP7; Retinoid-Binding Protein 7; Retinol Binding Protein 7; CRABP4; CRBPIV; CRBP4; Cellular Retinoic Acid-Binding Protein IV; Putative Cellular Retinol-Binding Protein CRBP IV; Cellular Retinoic Acid-Binding Protein 4; RBP7 Protein; Retinol Binding Prote
Species:
Human
Source:
E. coli
Cat. No.: HY-185133
CAS No.: 3107328-23-1
Target:
Research Areas:
RBP4-IN-3 (Compound 38) is a retinol-binding protein 4 (RBP4) inhibitor. RBP4-IN-3 can be used in studies related to cardiovascular diseases and obesity.
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
